"FDA grants Cognito breakthrough designation in Al
Post# of 1460
(Total Views: 318)
Posted On: 01/12/2021 12:05:39 PM
"FDA grants Cognito breakthrough designation in Alzheimer’s
Cognito Therapeutics has received a breakthrough device designation for one of the toughest fields in the industry — Alzheimer’s disease.
The FDA handed down the designation Tuesday morning, Cognito announced, saying the agency is planning to review its lead product for the treatment of cognitive and functional symptoms associated with Alzheimer’s.
Cognito says it has developed a non-invasive device that uses gamma frequency technology to stem Alzheimer’s symptoms. Researchers at the company say they found stimulating the brain at a specific frequency had the effect of reactivating the immune system in the brain, correlating with a reduction in amyloid plaques and tau tangles.
In practice, this could look like an Alzheimer’s patient being exposed to strobe lights and clicking sounds. A study in mice appeared to show improvements in cognitive and memory skills, per the New York Times.
Within that study, light and sound delivered to mice at 40 hertz, or 40 flashes or clicks per second, ostensibly synchronized with the rhythm of the brain’s gamma waves. That led to an increase in trash-clearing and immune-regulating functions within the brains. — Max Gelman
It's the second short article:
https://endpts.com/news-briefing-abbvie-selec...nt-device/
Cognito Therapeutics has received a breakthrough device designation for one of the toughest fields in the industry — Alzheimer’s disease.
The FDA handed down the designation Tuesday morning, Cognito announced, saying the agency is planning to review its lead product for the treatment of cognitive and functional symptoms associated with Alzheimer’s.
Cognito says it has developed a non-invasive device that uses gamma frequency technology to stem Alzheimer’s symptoms. Researchers at the company say they found stimulating the brain at a specific frequency had the effect of reactivating the immune system in the brain, correlating with a reduction in amyloid plaques and tau tangles.
In practice, this could look like an Alzheimer’s patient being exposed to strobe lights and clicking sounds. A study in mice appeared to show improvements in cognitive and memory skills, per the New York Times.
Within that study, light and sound delivered to mice at 40 hertz, or 40 flashes or clicks per second, ostensibly synchronized with the rhythm of the brain’s gamma waves. That led to an increase in trash-clearing and immune-regulating functions within the brains. — Max Gelman
It's the second short article:
https://endpts.com/news-briefing-abbvie-selec...nt-device/
(1)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼